Are nurse and pharmacist independent prescribers making clinically appropriate prescribing decisions? An analysis of consultations

Latter, Sue; Smith, Alesha; Blenkinsopp, Alison; Nicholls, Peter; Little, Paul; Chapman, Stephen

doi:10.1258/jhsrp.2012.011090

Cited by 67 publications

(89 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Raters felt that there was room for improvement in the history taking, assessment and diagnostic skills of NMPs, but concluded that overall NMPs were making clinically appropriate prescribing decisions [Latter et al 2012].…”

Section: Impact Of Nonmedical Prescribingmentioning

confidence: 99%

Nonmedical prescribing: where are we now?

Cope¹,

Abuzour

Tully

2016

Therapeutic Advances in Drug Safety

136

131

View full text Add to dashboard Cite

Nonmedical prescribing has been allowed in the United Kingdom (UK) since 1992. Its development over the past 24 years has been marked by changes in legislation, enabling the progression towards independent prescribing for nurses, pharmacists and a range of allied health professionals. Although the UK has led the way regarding the introduction of nonmedical prescribing, it is now seen in a number of other Western-European and Anglophone countries although the models of application vary widely between countries. The programme of study to become a nonmedical prescriber (NMP) within the UK is rigorous, and involves a combination of taught curricula and practice-based learning. Prescribing is a complex skill that is high risk and error prone, with many influencing factors. Literature reports regarding the impact of nonmedical prescribing are sparse, with the majority of prescribing research tending to focus instead on prescribing by doctors. The impact of nonmedical prescribing however is important to evaluate, and can be carried out from several perspectives. This review takes a brief look back at the history of nonmedical prescribing, and compares this with the international situation. It also describes the processes required to qualify as a NMP in the UK, potential influences on nonmedical prescribing and the impact of nonmedical prescribing on patient opinions and outcomes and the opinions of doctors and other healthcare professionals.

show abstract

Section: Impact Of Nonmedical Prescribingmentioning

confidence: 99%

Nonmedical prescribing: where are we now?

Cope¹,

Abuzour

Tully

2016

Therapeutic Advances in Drug Safety

136

131

View full text Add to dashboard Cite

show abstract

“…At the same time, national studies of supplementary prescribing (Bissell et al, 2008) mental health nurse prescribing (Norman et al, 2010) and independent prescribing in Ireland (Naughton et al, 2013) all showed largely positive findings, and so helped build support and confidence for nurse prescribing in the UK. Studies demonstrate that the prescription of medication by nurses is safe and competent, has led to better access and quality of care for patients, improvements in the abilities and experience of nurses, increased professional recognition, the legitimation of responsible autonomous practice and enabled better team working between the various healthcare professionals (Latter et al, 2012;Kroezen et al, 2011;Bhanbhro et al, 2011). Kroezen et al (2011) state that patient support and grassroots legislative constituency are crucial in battles over prescribing rights and these UK national studies all consistently reported patient support for nurse prescribing.…”

mentioning

confidence: 99%

Medication prescription by nurses and the case of the Brazil: What can we learn from international research?

Martiniano

Coêlho

Latter

et al. 2014

International Journal of Nursing Studies

Self Cite

View full text Add to dashboard Cite

This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and education use, including for instruction at the authors institution and sharing with colleagues.Other uses, including reproduction and distribution, or selling or licensing copies, or posting to personal, institutional or third party websites are prohibited.

show abstract

“…However, other healthcare workers also play an important role in AMS at the individual patient level including junior and senior doctors, nurses, non-medical prescribers and ward pharmacists. [36][37][38][39][40][41] Inclusion of these professional groups in user-testing at the design stage of EPMA implementation is likely to be critical to the success of the proposed software features. Future surveys focussing on front-line prescribers and medication administrators are critical.…”

Section: Discussionmentioning

confidence: 99%

Electronic prescribing system design priorities for antimicrobial stewardship: a cross-sectional survey of 142 UK infection specialists

Hand

Cumming

Hopkins

et al. 2016

J. Antimicrob. Chemother.

View full text Add to dashboard Cite

SynopsisThe implementation of electronic prescribing and medication administration systems (EPMAs) is a priority for hospitals and a potential component of antimicrobial stewardship (AMS). ObjectivesThis study aimed to identify software features within EPMAs that could potentially facilitate AMS and to survey practising UK infection specialist healthcare professionals in order to assign priority to these software features. MethodsA questionnaire was developed using nominal group technique and transmitted via email links through professional networks. The questionnaire collected demographic data, information on priority areas and anticipated impact of EPMA. Responses from different respondent groups were compared using the Mann Whitney U test. ResultsResponses were received from 164 individuals (142 analysable). Respondents were predominantly specialist infection pharmacists (48%) or medical microbiologists (37%). 59% of pharmacists had experience of EPMA in their hospitals compared to 35% of microbiologists. Pharmacists assigned higher priority to: indication prompt (p<0.001), allergy checker (p=0.003) treatment protocols (p=0.003), drug-indication mismatch alerts (p=0.031) and prolonged course alerts (p=0.041); and lower priority to a dose checker for adults (p=0.02) and an interaction checker (p<0.05), than microbiologists. A "soft stop" functionality was rated essential or a high priority by 89% of respondents. Potential EPMA software features were expected to have the greatest impact on stewardship, treatment efficacy and patient safety outcomes with lowest impact on Clostridium difficile infection (CDI), antimicrobial resistance and drug expenditure. ConclusionsThe survey demonstrates key differences in health professionals' opinions of different healthcare benefits of EPMA but a consensus of anticipated positive impact on patient safety and antimicrobial stewardship.

show abstract

Are nurse and pharmacist independent prescribers making clinically appropriate prescribing decisions? An analysis of consultations

Abstract: Bradford Scholars -how to deposit your paper Overview Copyright check• Check if your publisher allows submission to a repository.• Use the Sherpa RoMEO database if you are not sure about your publisher's position or email openaccess@bradford.ac.uk.

Cited by 67 publications

References 20 publications

Nonmedical prescribing: where are we now?

Nonmedical prescribing: where are we now?

Medication prescription by nurses and the case of the Brazil: What can we learn from international research?

Electronic prescribing system design priorities for antimicrobial stewardship: a cross-sectional survey of 142 UK infection specialists

Contact Info

Product

Resources

About